Compare SRRK & MUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRRK | MUR |
|---|---|---|
| Founded | 2012 | 1950 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.9B |
| IPO Year | 2018 | 1994 |
| Metric | SRRK | MUR |
|---|---|---|
| Price | $45.04 | $38.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 15 |
| Target Price | ★ $55.40 | $30.92 |
| AVG Volume (30 Days) | 1.1M | ★ 2.5M |
| Earning Date | 03-03-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.67% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | N/A | ★ $2,718,823,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $449.79 | $14.67 |
| P/E Ratio | ★ N/A | $53.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.71 | $18.95 |
| 52 Week High | $49.82 | $38.37 |
| Indicator | SRRK | MUR |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 66.97 |
| Support Level | $41.54 | $29.81 |
| Resistance Level | $48.29 | N/A |
| Average True Range (ATR) | 2.49 | 1.40 |
| MACD | -0.28 | 0.40 |
| Stochastic Oscillator | 62.43 | 92.56 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Murphy Oil Corp is an oil and gas exploration and production company, with both onshore and offshore operations and properties. It operates in two geographic reportable segments the United States and Canada. It generates the majority of its revenue form the United States. The company also generates revenue from sales of oil and natural gas production activities.